read the press release carefully - they stopped the trail but fully intend to continue once they fine tune. This is very normal when your testing and they did not cover-up or delay but brought it out in the open, Remember every major player is invested in Omed. Take advantage of this dip and don't forget they have other things in the pipe line -not a one drug wonder. Don't panic, the turtle wins the race. tanks for the under 21 gifts.
this was a great opportunity to pick up some shares, now long and strong. The sell off, in my humble opinion, was overdone. What happened is something to expect from a P1 trial, and it is good it happened during this trial and not during the P2 or P3. Other positions are NPSP, ITMN, ACRX, TTPH, GILD, PCYC, MGNX, RLYP, LGND. CLDX, ACAD, SGEN, PTX - a little too focussed on Bio/Pharma but this is where real $$ can be made.